Bellevue Group AG Takes $16.51 Million Position in STERIS plc (NYSE:STE)

Bellevue Group AG bought a new stake in STERIS plc (NYSE:STE) in the first quarter, according to the company in its most recent Form 13F filing with the SEC. The fund bought 73,434 shares of the medical equipment provider’s stock, valued at approximately $16,509,000.

A number of other hedge funds and other institutional investors also recently modified their holdings of STE. First Personal Financial Services bought a new stake in shares of STERIS in the 1st quarter valued at about $25,000. J.Safra Asset Management Corp lifted its stake in shares of STERIS by 77.9% in the 1st quarter. J.Safra Asset Management Corp now owns 121 shares of the medical equipment provider’s stock valued at $27,000 after acquiring an additional 53 shares during the last quarter. Quent Capital LLC increased its holdings in STERIS by 112.7% during the 1st quarter. Quent Capital LLC now owns 134 shares of the medical equipment provider’s stock valued at $30,000 after purchasing an additional 71 shares during the period. VisionPoint Advisory Group LLC purchased a new position in STERIS during the 4th quarter valued at about $34,000. Finally, Headlands Technologies LLC purchased a new position in STERIS during the 1st quarter valued at about $36,000. Institutional investors own 94.69% of the company’s stock.

Analyst Ratings Changes

A number of research analysts recently issued reports on the company. JMP Securities restated a “market outperform” rating and set a $265.00 price target on shares of STERIS in a report on Friday. Piper Sandler restated a “neutral” rating and set a $225.00 price target (up previously from $220.00) on shares of STERIS in a report on Friday, May 10th. Needham & Company LLC restated a “hold” rating on shares of STERIS in a report on Friday, May 10th. Finally, StockNews.com upgraded STERIS from a “hold” rating to a “buy” rating in a report on Saturday, June 15th. Three investment analysts have rated the stock with a hold rating and four have given a buy rating to the company’s stock. According to data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and a consensus target price of $241.60.

Insider Transactions at STERIS

In other news, SVP Cary L. Majors sold 2,024 shares of the business’s stock in a transaction that occurred on Monday, May 13th. The stock was sold at an average price of $232.13, for a total value of $469,831.12. Following the sale, the senior vice president now directly owns 11,369 shares of the company’s stock, valued at approximately $2,639,085.97. The sale was disclosed in a legal filing with the SEC, which is accessible through the SEC website. In related news, VP Renato Tamaro sold 1,154 shares of the company’s stock in a transaction that occurred on Thursday, May 16th. The stock was sold at an average price of $231.64, for a total value of $267,312.56. Following the transaction, the vice president now directly owns 6,677 shares of the company’s stock, valued at approximately $1,546,660.28. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, SVP Cary L. Majors sold 2,024 shares of the company’s stock in a transaction that occurred on Monday, May 13th. The shares were sold at an average price of $232.13, for a total value of $469,831.12. Following the completion of the transaction, the senior vice president now directly owns 11,369 shares in the company, valued at $2,639,085.97. The disclosure for this sale can be found here. Insiders have sold a total of 7,762 shares of company stock valued at $1,798,477 in the last ninety days. 1.14% of the stock is currently owned by corporate insiders.

STERIS Stock Up 2.3 %

Shares of STE stock traded up $5.23 during midday trading on Friday, reaching $232.79. 329,376 shares of the stock were exchanged, compared to its average volume of 405,734. STERIS plc has a 1 year low of $195.47 and a 1 year high of $254.00. The company’s 50 day moving average is $223.23 and its two-hundred day moving average is $221.83. The company has a current ratio of 3.08, a quick ratio of 2.36 and a debt-to-equity ratio of 0.49. The firm has a market cap of $23.01 billion, a PE ratio of 60.94 and a beta of 0.83.

STERIS (NYSE:STE) last posted its earnings results on Wednesday, May 8th. The medical equipment provider reported $2.58 earnings per share for the quarter, topping analysts’ consensus estimates of $2.41 by $0.17. STERIS had a return on equity of 13.73% and a net margin of 6.95%. The firm had revenue of $1.42 billion for the quarter, compared to the consensus estimate of $1.41 billion. During the same quarter in the prior year, the business earned $2.30 EPS. The business’s revenue for the quarter was up 10.8% on a year-over-year basis. On average, equities research analysts predict that STERIS plc will post 9.25 EPS for the current year.

STERIS Dividend Announcement

The business also recently declared a quarterly dividend, which was paid on Wednesday, June 26th. Stockholders of record on Wednesday, June 12th were given a $0.52 dividend. The ex-dividend date was Wednesday, June 12th. This represents a $2.08 dividend on an annualized basis and a dividend yield of 0.89%. STERIS’s dividend payout ratio is currently 54.45%.

STERIS Company Profile

STERIS plc provides infection prevention products and services worldwide. It operates through four segments: Healthcare, Applied Sterilization Technologies, Life Sciences, and Dental. The Healthcare segment offers cleaning chemistries and sterility assurance products; automated endoscope reprocessing system and tracking products; endoscopy accessories, washers, sterilizers, and other pieces of capital equipment for the operation of a sterile processing department; and equipment used directly in the operating room, including surgical tables, lights, and connectivity solutions, as well as equipment management services.